Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ORYZON to Present New Clinical Data and Corporate Updates at Conferences in February and March
Oryzon Genomics, S.A.February 10, 2021 GMT
2021 BIO CEO & Investor Digital Conference
15th International Conference on Alzheimer’s and Parkinson’s Diseases AD/PD 2021
H.C. Wainwright Global Life Sciences Conference
BioCapital Europe 2021
33rd Annual ROTH Conference
MADRID, Spain and CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announces that it will present new clinical data and attend several industry conferences in February and March, all in virtual format due to the Covid-19 pandemic.